cyclosporine and Peritoneal Diseases

cyclosporine has been researched along with Peritoneal Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bes, C; Erdogan, M; Yalcin Mutlu, M; Yardimci, AH; Yıldırım, F1
Chen, C; Chen, YP; Gu, HY; Guo, LY; He, H; Li, XD; Shen, LL; Wang, YF; Xia, DL1
Bozkurt, D; Cetin, P; Duman, S; Ertilav, M; Hur, E; Ozdemir, O; Sen, S; Sipahi, S1
Aten, J; de Boer, OJ; de Waart, DR; Hajji, N; Krediet, RT; Kunne, C; van Westrhenen, R1

Other Studies

4 other study(ies) available for cyclosporine and Peritoneal Diseases

ArticleYear
Efficacy of cyclosporine in a patient with lupus mesenteric vasculitis refractory to conventional immunosuppressive therapy.
    Lupus, 2021, Volume: 30, Issue:11

    Topics: Adult; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mesentery; Peritoneal Diseases; Splanchnic Circulation; Vasculitis

2021
Effect of "phase change" complex on postoperative adhesion prevention.
    The Journal of surgical research, 2016, May-01, Volume: 202, Issue:1

    Topics: Absorbable Implants; Animals; Biocompatible Materials; Calcium Chloride; Chitosan; Cyclosporine; Drug Combinations; Female; Immunosuppressive Agents; Intestines; Male; Peritoneal Diseases; Postoperative Complications; Rats; Rats, Sprague-Dawley; Single-Blind Method; Tissue Adhesions; Treatment Outcome

2016
Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis?
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2009, Volume: 29 Suppl 2

    Topics: Animals; Azathioprine; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glucocorticoids; Immunosuppression Therapy; Immunosuppressive Agents; Peritoneal Dialysis; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Sclerosis; Treatment Outcome

2009
Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.
    Blood purification, 2007, Volume: 25, Issue:5-6

    Topics: Animals; Cyclosporine; Fibrosis; Glucose; Hemodialysis Solutions; Lactic Acid; Male; Neovascularization, Pathologic; Peritoneal Dialysis; Peritoneal Diseases; Rats; Rats, Wistar

2007